Rare Compute is on a mission to revolutionize rare disease research by harnessing the untapped potential of decentralized technologies. We're driven by a simple yet powerful vision - to bring hope and breakthrough treatments to the 25-30 million Americans impacted by the over 7,000 known rare diseases, 95% of which have no FDA-approved therapy.
Rare diseases are a silent epidemic, marked by diagnostic odysseys that can span years, limited research funding, and heartbreakingly high mortality rates, especially among children. The very nature of these conditions, with their small patient populations scattered across the globe, makes them incredibly difficult to study and treat.
That's where Rare Compute comes in. We've built an innovative decentralized biotech platform that leverages blockchain technology and tokenized compute to break down the barriers holding back rare disease research. Our collaborative data tools empower scientists worldwide to share resources and insights in ways never before possible. And by scaling costs through decentralized infrastructure and enabling collective governance models, we're poised to accelerate the pace of discovery like never before.
The opportunity is immense. The rare disease treatment market exceeded $195 billion globally in 2022 and is projected to reach a staggering $435 billion by 2032. With 90% of rare diseases still lacking treatments, there's a vast unmet need waiting to be addressed. As a first-mover in the decentralized biotech space, Rare Compute is uniquely positioned to capture this potential.
Our business model is anchored around providing ZK proofs, tokenized compute, and hardware leasing. We care about preserving privacy and as such leverage fully homomorphic encryption with all our data storage. We're led by a world-class team of entrepreneurs and scientists who have developed a phased plan to rapidly scale our infrastructure and maximize our impact for patients.
If you share our vision for a world where no rare disease is too rare to treat, we invite you to join us. Together, we can pioneer the future of decentralized biotechnology and make the impossible possible for rare disease patients everywhere. The revolution starts now, and it starts with Rare Compute.
